• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前瞻性脓毒症和脓毒性休克队列中初始晶体液复苏及时性相关的模式及结果

Patterns and Outcomes Associated With Timeliness of Initial Crystalloid Resuscitation in a Prospective Sepsis and Septic Shock Cohort.

作者信息

Leisman Daniel E, Goldman Chananya, Doerfler Martin E, Masick Kevin D, Dries Susan, Hamilton Eric, Narasimhan Mangala, Zaidi Gulrukh, D'Amore Jason A, D'Angelo John K

机构信息

1Department of Emergency Medicine, Hofstra-Northwell School of Medicine, Hempstead, NY. 2Emergency Medicine Service Line, Northwell Health, New Hyde Park, NY. 3Icahn School of Medicine at Mount Sinai, New York, NY. 4Department of Medicine, Northwell Health System, Hofstra-Northwell School of Medicine, Manhasset, NY. 5Department of Science Education, Hofstra-Northwell School of Medicine, Hempstead, NY. 6Kransoff Quality Mangement Institute, Northwell Health, New Hyde Park, NY. 7Division of Pulmonary, Critical Care, and Sleep Medicine, Northwell Health System, Hofstra-Northwell School of Medicine, Manhasset, NY.

出版信息

Crit Care Med. 2017 Oct;45(10):1596-1606. doi: 10.1097/CCM.0000000000002574.

DOI:10.1097/CCM.0000000000002574
PMID:28671898
Abstract

OBJECTIVES

The objectives of this study were to 1) assess patterns of early crystalloid resuscitation provided to sepsis and septic shock patients at initial presentation and 2) determine the association between time to initial crystalloid resuscitation with hospital mortality, mechanical ventilation, ICU utilization, and length of stay.

DESIGN

Consecutive-sample observational cohort.

SETTING

Nine tertiary and community hospitals over 1.5 years.

PATIENTS

Adult sepsis and septic shock patients captured in a prospective quality improvement database inclusion criteria: suspected or confirmed infection, greater than or equal to two systemic inflammatory response criteria, greater than or equal to one organ-dysfunction criteria.

INTERVENTIONS

The primary exposure was crystalloid initiation within 30 minutes or lesser, 31-120 minutes, or more than 120 minutes from sepsis identification.

MEASUREMENTS AND MAIN RESULTS

We identified 11,182 patients. Crystalloid initiation was faster for emergency department patients (β, -141 min; CI, -159 to -125; p < 0.001), baseline hypotension (β, -39 min; CI, -48 to -32; p < 0.001), fever, urinary or skin/soft-tissue source of infection. Initiation was slower with heart failure (β, 20 min; CI, 14-25; p < 0.001), and renal failure (β, 16 min; CI, 10-22; p < 0.001). Five thousand three hundred thirty-six patients (48%) had crystalloid initiated in 30 minutes or lesser versus 2,388 (21%) in 31-120 minutes, and 3,458 (31%) in more than 120 minutes. The patients receiving fluids within 30 minutes had lowest mortality (949 [17.8%]) versus 31-120 minutes (446 [18.7%]) and more than 120 minutes (846 [24.5%]). Compared with more than 120 minutes, the adjusted odds ratio for mortality was 0.76 (CI, 0.64-0.90; p = 0.002) for 30 minutes or lesser and 0.76 (CI, 0.62-0.92; p = 0.004) for 31-120 minutes. When assessed continuously, mortality odds increased by 1.09 with each hour to initiation (CI, 1.03-1.16; p = 0.002). We observed similar patterns for mechanical ventilation, ICU utilization, and length of stay. We did not observe significant interaction for mortality risk between initiation time and baseline heart failure, renal failure, hypotension, acute kidney injury, altered gas exchange, or emergency department (vs inpatient) presentation.

CONCLUSIONS

Crystalloid was initiated significantly later with comorbid heart failure and renal failure, with absence of fever or hypotension, and in inpatient-presenting sepsis. Earlier crystalloid initiation was associated with decreased mortality. Comorbidities and severity did not modify this effect.

摘要

目的

本研究的目的是:1)评估脓毒症和脓毒性休克患者初次就诊时早期晶体复苏的模式;2)确定初始晶体复苏时间与医院死亡率、机械通气、重症监护病房(ICU)使用情况及住院时间之间的关联。

设计

连续抽样观察性队列研究。

地点

1.5年期间的9家三级医院和社区医院。

患者

前瞻性质量改进数据库中纳入的成年脓毒症和脓毒性休克患者,纳入标准:疑似或确诊感染、≥两条全身炎症反应标准、≥一条器官功能障碍标准。

干预措施

主要暴露因素为从脓毒症确诊起30分钟及以内、31 - 120分钟或超过120分钟开始进行晶体复苏。

测量指标及主要结果

我们共纳入11182例患者。急诊科患者晶体复苏开始时间更早(β,-141分钟;95%置信区间,-159至-125;p < 0.001),基线低血压患者(β,-39分钟;95%置信区间,-48至-32;p < 0.001)、发热患者、感染源为泌尿系统或皮肤/软组织的患者也是如此。心力衰竭患者(β,20分钟;95%置信区间,14 - 25;p < 0.001)和肾衰竭患者(β,16分钟;95%置信区间,10 - 22;p < 0.001)晶体复苏开始时间较晚。5336例患者(48%)在30分钟及以内开始进行晶体复苏,2388例患者(21%)在31 - 120分钟开始,345例患者(31%)在超过120分钟开始。在30分钟及以内接受补液的患者死亡率最低(949例[17.8%]),而在31 - 120分钟开始补液的患者死亡率为446例(18.7%),超过120分钟开始补液的患者死亡率为846例(24.5%)。与超过120分钟开始补液相比,30分钟及以内开始补液的患者死亡调整比值比为0.76(95%置信区间,0.64 - 0.90;p = 0.002),31 - 120分钟开始补液的患者死亡调整比值比为0.76(95%置信区间,0.62 - 0.92;p = 0.004)。连续评估时,每延迟一小时开始补液,死亡几率增加1.09(95%置信区间,1.03 - 1.16;p = 0.002)。我们在机械通气、ICU使用情况及住院时间方面观察到类似模式。我们未观察到开始时间与基线心力衰竭、肾衰竭、低血压、急性肾损伤、气体交换改变或急诊科(与住院患者相比)就诊情况之间在死亡风险上存在显著交互作用。

结论

合并心力衰竭和肾衰竭、无发热或低血压以及住院患者脓毒症患者晶体复苏开始时间显著延迟。更早开始晶体复苏与死亡率降低相关。合并症和病情严重程度并未改变这一效应。

相似文献

1
Patterns and Outcomes Associated With Timeliness of Initial Crystalloid Resuscitation in a Prospective Sepsis and Septic Shock Cohort.前瞻性脓毒症和脓毒性休克队列中初始晶体液复苏及时性相关的模式及结果
Crit Care Med. 2017 Oct;45(10):1596-1606. doi: 10.1097/CCM.0000000000002574.
2
Association of Fluid Resuscitation Initiation Within 30 Minutes of Severe Sepsis and Septic Shock Recognition With Reduced Mortality and Length of Stay.严重脓毒症和脓毒性休克识别后30分钟内开始液体复苏与降低死亡率及缩短住院时间的关联。
Ann Emerg Med. 2016 Sep;68(3):298-311. doi: 10.1016/j.annemergmed.2016.02.044. Epub 2016 Apr 14.
3
Evaluation and Predictors of Fluid Resuscitation in Patients With Severe Sepsis and Septic Shock.严重脓毒症和脓毒性休克患者液体复苏的评估和预测因素。
Crit Care Med. 2019 Nov;47(11):1582-1590. doi: 10.1097/CCM.0000000000003960.
4
Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database.严重脓毒症和脓毒性休克中的液体管理、模式和结局:对大型国家数据库的分析。
Intensive Care Med. 2017 May;43(5):625-632. doi: 10.1007/s00134-016-4675-y. Epub 2017 Jan 27.
5
Predictors, Prevalence, and Outcomes of Early Crystalloid Responsiveness Among Initially Hypotensive Patients With Sepsis and Septic Shock.最初低血压的脓毒症和感染性休克患者早期晶体液反应性的预测因素、患病率和结局。
Crit Care Med. 2018 Feb;46(2):189-198. doi: 10.1097/CCM.0000000000002834.
6
Association Between Volume of Fluid Resuscitation and Intubation in High-Risk Patients With Sepsis, Heart Failure, End-Stage Renal Disease, and Cirrhosis.容量复苏与高危患者脓毒症、心力衰竭、终末期肾病和肝硬化患者插管的关系。
Chest. 2020 Feb;157(2):286-292. doi: 10.1016/j.chest.2019.09.029. Epub 2019 Oct 14.
7
Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.单独使用合成胶体或晶体液复苏对严重脓毒症休克逆转、液体平衡和患者结局的影响:一项前瞻性序贯分析。
Crit Care Med. 2012 Sep;40(9):2543-51. doi: 10.1097/CCM.0b013e318258fee7.
8
Assessment of Outcomes in Patients with Heart Failure and End-Stage Kidney Disease after Fluid Resuscitation for Sepsis and Septic Shock.评估脓毒症和感染性休克液体复苏后心力衰竭和终末期肾病患者的结局。
J Emerg Med. 2024 Jun;66(6):e670-e679. doi: 10.1016/j.jemermed.2024.02.001. Epub 2024 Feb 16.
9
Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*.严重脓毒症患者晶体液选择与院内死亡率的关系*。
Crit Care Med. 2014 Jul;42(7):1585-91. doi: 10.1097/CCM.0000000000000305.
10
Impact of Source Control in Patients With Severe Sepsis and Septic Shock.严重脓毒症和感染性休克患者的源头控制的影响。
Crit Care Med. 2017 Jan;45(1):11-19. doi: 10.1097/CCM.0000000000002011.

引用本文的文献

1
The Association Between Time to Completion of at Least 30 mL/kg and Hospital Outcomes Among Patients With Septic Shock.脓毒性休克患者至少完成30 mL/kg的时间与医院结局之间的关联
Crit Care Explor. 2025 Apr 28;7(5):e1253. doi: 10.1097/CCE.0000000000001253. eCollection 2025 May 1.
2
Fluid Resuscitation and Initial Management in Patients Presenting with Sepsis in the General Ward.普通病房脓毒症患者的液体复苏与初始管理
Life (Basel). 2025 Jan 18;15(1):124. doi: 10.3390/life15010124.
3
Culture-negative sepsis may be a different entity from culture-positive sepsis: a prospective nationwide multicenter cohort study.
培养阴性脓毒症可能与培养阳性脓毒症不同:一项前瞻性全国多中心队列研究。
Crit Care. 2024 Nov 25;28(1):385. doi: 10.1186/s13054-024-05151-3.
4
Optimal fluid resuscitation targets in septic patients with acutely decompensated heart failure.脓毒症合并急性失代偿性心力衰竭患者的最佳液体复苏目标。
BMC Med. 2024 Oct 24;22(1):492. doi: 10.1186/s12916-024-03715-2.
5
Relationship Between Fluid Administration During the First Three Hours of Sepsis Resuscitation and Mortality: A Multicenter Observational Study.脓毒症复苏最初三小时内液体输注与死亡率的关系:一项多中心观察性研究
Cureus. 2024 Jul 26;16(7):e65480. doi: 10.7759/cureus.65480. eCollection 2024 Jul.
6
Associations Between Volume of Early Intravenous Fluid and Hospital Outcomes in Septic Patients With and Without Heart Failure: A Retrospective Cohort Study.早期静脉输液量与伴或不伴心力衰竭的脓毒症患者住院结局的相关性:一项回顾性队列研究。
Crit Care Explor. 2024 Apr 26;6(5):e1082. doi: 10.1097/CCE.0000000000001082. eCollection 2024 May.
7
Protocol for a systematic review and meta-analysis assessing conservative versus liberal intravenous fluid administration in patients with sepsis or septic shock at risk of fluid overload.评估在有发生液体超负荷风险的脓毒症或脓毒性休克患者中,保守与宽松静脉输液治疗的系统评价和荟萃分析方案。
BMJ Open. 2023 May 24;13(5):e069601. doi: 10.1136/bmjopen-2022-069601.
8
Prediction of septic and hypovolemic shock in intensive care unit patients using machine learning.利用机器学习预测重症监护病房患者的感染性休克和低血容量性休克。
Rev Bras Ter Intensiva. 2022 Oct-Dec;34(4):477-483. doi: 10.5935/0103-507X.20220280-pt. Epub 2023 Mar 3.
9
Fluid resuscitation and outcomes in heart failure patients with severe sepsis or septic shock: A retrospective case-control study.严重脓毒症或感染性休克心力衰竭患者的液体复苏与结局:一项回顾性病例对照研究。
PLoS One. 2021 Aug 19;16(8):e0256368. doi: 10.1371/journal.pone.0256368. eCollection 2021.
10
Predicting mortality among septic patients presenting to the emergency department-a cross sectional analysis using machine learning.运用机器学习分析对急诊科就诊的脓毒症患者进行死亡率预测:一项横断面研究
BMC Emerg Med. 2021 Jul 12;21(1):84. doi: 10.1186/s12873-021-00475-7.